Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2005
09/14/2005EP1573334A1 Method for analyzing tumor agressivity comprising measurement of polymerized actin
09/14/2005EP1573333A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2)
09/14/2005EP1573332A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3)
09/14/2005EP1573331A1 Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1)
09/14/2005EP1573330A1 Self-calibrated flow-through assay devices
09/14/2005EP1573329A1 Biosensor with rf signal transmission
09/14/2005EP1573328A1 Biochip
09/14/2005EP1573327A1 Dna chip comprising a microarray made of an microelectrode system
09/14/2005EP1573326A1 Reduction of the hook effect in membrane-based assay devices
09/14/2005EP1573325A1 Particles
09/14/2005EP1573324A2 Cytochrome c acetylation
09/14/2005EP1573323A2 Prion protein ligands and methods of use
09/14/2005EP1573322A2 METHODS OF SCREENING FOR TRPM4b MODULATORS
09/14/2005EP1573317A2 Method of using animal models to predict adverse drug reactions
09/14/2005EP1573316A2 Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (egfr) extracellular domain (ecd) analyte, alone or in combination with other analytes, in body fluid samples
09/14/2005EP1573315A1 Predictive crude oil compatibility model
09/14/2005EP1573314A2 Transgenic mice expressing human cd20
09/14/2005EP1573313A2 Transgenic mice expressing human cd20 and/or cd16
09/14/2005EP1573311A2 Information notification sample processing system and methods of biological slide processing
09/14/2005EP1573296A2 A milk conveyer device
09/14/2005EP1573294A2 Real time detection of intermolecular interaction
09/14/2005EP1573072A2 Cell-based analysis of high throughput screening data for drug discovery
09/14/2005EP1573071A2 Methods for detecting invasion of a cell
09/14/2005EP1573069A2 Amplified cancer target genes useful in diagnosis and therapeutic screening
09/14/2005EP1573064A2 Method for determining markers of human facial skin
09/14/2005EP1573061A1 Multiplexed immunohistochemical assays using molecular tags
09/14/2005EP1573060A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene
09/14/2005EP1573059A1 Method of identification and quantification of proteins, isoforms of the angiotensin i converting enzyme
09/14/2005EP1573056A2 Methods for fragmentation, labeling and immobilization of nucleic acids
09/14/2005EP1573054A2 Diagnosis of sepsis or sirs using biomarker profiles
09/14/2005EP1573048A2 Breast specific protein expressed in cancer and methods of use thereof
09/14/2005EP1573045A2 Heart failure gene determination and therapeutic screening
09/14/2005EP1573044A2 Serum biomarkers in lung cancer
09/14/2005EP1573039A2 Compositions and methods for diagnosing and treating mood disorders
09/14/2005EP1573035A2 Brother of the regulator of imprinted sites (boris)
09/14/2005EP1573034A2 Identification and modulation of a g-protein coupled receptor (gpcr), rai3, associated with chronic obstructive pulmonary disease (copd) and nf-kb and e-selectin regulation
09/14/2005EP1573033A2 Animal genotyping method
09/14/2005EP1573032A2 Human il-18 crystal structure
09/14/2005EP1573031A2 Androgen regulated nucleic acid molecules and encoded proteins
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1573027A2 Method of reducing angiogenesis
09/14/2005EP1573026A2 Mre11: modulation of cellular proliferation
09/14/2005EP1573025A2 Crystallized structure of type iv collagen nc1 domain hexamer
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1573016A2 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein
09/14/2005EP1573004A2 Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
09/14/2005EP1572999A1 Method of diagnosis of obesity
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572978A2 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
09/14/2005EP1572974A2 Polynucleotide sequence detection assays and analysis
09/14/2005EP1572973A2 Mracs as modifiers of the rac pathway and methods of use
09/14/2005EP1572969A2 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
09/14/2005EP1572965A2 Human sarcoma-associated antigens
09/14/2005EP1572961A2 Actriib fusion polypeptides and uses therefor
09/14/2005EP1572950A2 Single domain tdf-related compounds and analogs thereof
09/14/2005EP1572944A2 Methods and compositions for modulating xbp-1 activity
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572938A2 Polyvalent cation-sensing receptor in atlantic salmon
09/14/2005EP1572937A2 Motif-grafted hybrid polypeptides and uses thereof
09/14/2005EP1572935A2 Methods of making hypermutable cells using pmsr homologs
09/14/2005EP1572932A2 Reagents and methods for identifying and modulating expression of tumor senescence genes
09/14/2005EP1572925A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572916A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
09/14/2005EP1572913A2 Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192
09/14/2005EP1572907A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
09/14/2005EP1572905A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572891A2 Bone anti-resorptive compounds
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572888A2 Methods for generating, selecting, and identifying compounds which bind a target molecule
09/14/2005EP1572885A2 Methods for treating diabetes and other blood sugar disorders
09/14/2005EP1572884A2 Dominant negative variants of methionine aminopeptidase 2 (metap2) and clinical uses thereof
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572878A2 Compositions and methods for inferring a response to a statin
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572876A2 Transcriptional regulation of target genes
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572874A2 Antibodies that immunospecifically bind to trail receptors
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572871A2 T1r3 a novel taste receptor
09/14/2005EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572866A2 Insect nuclear receptor genes and uses thereof
09/14/2005EP1572865A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572862A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
09/14/2005EP1572743A2 Peptides and their use for the treatment of hiv infections
09/14/2005EP1572742A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
09/14/2005EP1572735A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes
09/14/2005EP1572730A2 Nact as a target for lifespan expansion and weight reduction
09/14/2005EP1572721A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
09/14/2005EP1572445A2 Fluorescent silica-based nanoparticles
09/14/2005EP1572363A2 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
09/14/2005EP1572352A2 Surface treatment
09/14/2005EP1572346A1 Surface treatment
09/14/2005EP1572311A2 Assay for determining the activity of fatty acid amide hydrolase
09/14/2005EP1572236A2 Levels of pin1 in normal and cancerous tissue
1 ... 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 ... 3937